BOSTON SCIENTIFIC CORPORATION Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
BOSTON SCIENTIFIC CORPORATION (BSX) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $106.00 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-02-17
- BOSTON SCIENTIFIC CORPORATION share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $106.00, a 63.08% increase from fiscal 2024.
- BOSTON SCIENTIFIC CORPORATION share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $65.00, a 38.30% increase from fiscal 2023.
- BOSTON SCIENTIFIC CORPORATION share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $47.00, a 6.82% increase from fiscal 2022.
- BOSTON SCIENTIFIC CORPORATION share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $44.00, a 16.74% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|
| 2025-12-31 | $106.00 10-K · filed 2026-02-17 | |
| 2024-12-31 | $65.00 10-K · filed 2026-02-17 | |
| 2023-12-31 | $47.00 10-K · filed 2026-02-17 | $47.43 10-K · filed 2024-02-20 |
| 2022-12-31 | $44.00 10-K · filed 2025-02-18 | $44.02 10-K · filed 2023-02-23 |
| 2021-12-31 | $37.69 10-K · filed 2024-02-20 | |
| 2020-12-31 | $41.79 10-K · filed 2023-02-23 | |
| 2019-12-31 | $40.20 10-K · filed 2022-02-23 | |
| 2018-12-31 | $27.26 10-K · filed 2021-02-23 | |
| 2017-12-31 | $24.70 10-K · filed 2020-02-25 | |
| 2016-12-31 | $17.46 10-K · filed 2019-02-19 | |
| 2015-12-31 | $16.49 10-K · filed 2018-02-20 | |
| 2014-12-31 | $13.02 10-K · filed 2017-02-23 | |
| 2013-12-31 | $7.44 10-K · filed 2016-02-24 | |
| 2012-12-31 | $6.23 10-K · filed 2015-02-25 | |
| 2011-12-31 | $7.11 10-K · filed 2014-02-26 | |
| 2010-12-31 | $7.26 8-K · filed 2013-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |